SCHEMBL25246791

SCHEMBL25246791

c1ccc2c(-c3c(-c4c(-c5cccc6c5ccc5ccccc56)ccc5c4ccc4ccccc45)ccc4ccccc34)cccc2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPRT1 P00492 3/20 0.52
ALDH1A1 P00352 5/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
CYP1A2 P05177 2/20 0.50
HPGD P15428 2/20 0.50
HIF1A Q16665 2/20 0.50
DNMT1 P26358 1/20 0.50
USP2 O75604 1/20 0.50
LMNA P02545 1/20 0.50
TP53 P04637 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
ALOX12 P18054 1/20 0.50
MAPK1 P28482 1/20 0.50
CYP2C19 P33261 1/20 0.50
HSD17B10 Q99714 3/20 0.44
TDP1 Q9NUW8 2/20 0.44
CYP2A6 P11509 1/20 0.44
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30022080 1.00 HPRT1 (0.52) HPRT1ALDH1A1MEN1KMT2ACYP1A2
SCHEMBL30332455 1.00 HPRT1 (0.52) HPRT1ALDH1A1MEN1KMT2ACYP1A2
SCHEMBL25402472 0.98 HPRT1 (0.54) HPRT1ALDH1A1MEN1KMT2ACYP1A2
SCHEMBL25401068 0.96 HPRT1 (0.56) HPRT1ALDH1A1MEN1KMT2ACYP1A2
SCHEMBL16700817 0.96 HPRT1 (0.56) HPRT1ALDH1A1MEN1KMT2ACYP1A2
SCHEMBL29177732 0.96 HPRT1 (0.56) HPRT1ALDH1A1MEN1KMT2ACYP1A2
SCHEMBL30022198 0.96 HPRT1 (0.56) HPRT1ALDH1A1MEN1KMT2ACYP1A2
SCHEMBL25403049 0.96 HPRT1 (0.56) HPRT1ALDH1A1MEN1KMT2ACYP1A2
SCHEMBL30022346 0.96 HPRT1 (0.56) HPRT1ALDH1A1MEN1KMT2ACYP1A2
SCHEMBL30333589 0.96 HPRT1 (0.56) HPRT1ALDH1A1MEN1KMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240407244-A1 MIXED POWDER FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND METHOD FOR PRODUCING THE SAME, METHOD FOR FABRICATING ORGANIC ELECTROLUMINESCENCE DEVICE BY USING THE MIXED POWDER, METHOD FOR SELECTING COMPOUNDS IN THE MIXED POWDER, AND COMPOSITION FOR VACUUM DEPOSITION IDEMITSU KOSAN CO.,LTD. (JP) 2024-12-05 US disclosed
US-20240334814-A1 MIXED POWDER, MIXTURE, AND METHOD FOR FABRICATING ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-10-03 US disclosed
WO-2023100891-A1 SOLID MOLTEN MIXTURE, SOLID COMPOSITION, MIXED POWDER, METHOD FOR CHOOSING ORGANIC COMPOUND, METHOD FOR PRODUCING SOLID MOLTEN MIXTURE, AND METHOD FOR PRODUCING ORGANIC ELECTROLUMINESCENT ELEMENT 出光興産株式会社 2023-06-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240334814-A1 MIXED POWDER, MIXTURE, AND METHOD FOR FABRICATING ORGANIC ELECTROLUMINESCENCE DEVICE EML4, ORC3, ZRANB2 HPRT1 2445/4885ALDH1A1 3661/4885MEN1 552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.